GlaxoSmithKline (GSK) reports Q1 results
Tweet
Share
E-mail
Get Alerts GSK Hot Sheet
Join SI Premium – FREE
GlaxoSmithKline (NYSE: GSK) reported Q1 EPS of GBP0.37. Revenue for the quarter came in at GBP6.95 billion.
For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
- Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
- Pfizer reaffirms 2026 guidance after CFO transition news
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
